These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors. Liu M; Sun Q; Wei F; Ren X Cancer Biol Med; 2020 Aug; 17(3):626-639. PubMed ID: 32944395 [TBL] [Abstract][Full Text] [Related]
6. Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer. Baraibar I; Melero I; Ponz-Sarvise M; Castanon E Drug Saf; 2019 Feb; 42(2):281-294. PubMed ID: 30649742 [TBL] [Abstract][Full Text] [Related]
7. Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know. Braschi-Amirfarzan M; Tirumani SH; Hodi FS; Nishino M Korean J Radiol; 2017; 18(1):42-53. PubMed ID: 28096717 [TBL] [Abstract][Full Text] [Related]
8. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis. Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X Front Immunol; 2021; 12():645170. PubMed ID: 33897693 [TBL] [Abstract][Full Text] [Related]
9. The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response. Luo M; Fu L Oncotarget; 2016 May; 7(20):29794-803. PubMed ID: 26919108 [TBL] [Abstract][Full Text] [Related]
10. Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy. Constantinidou A; Alifieris C; Trafalis DT Pharmacol Ther; 2019 Feb; 194():84-106. PubMed ID: 30268773 [TBL] [Abstract][Full Text] [Related]
11. Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives. Mocan T; Sparchez Z; Craciun R; Bora CN; Leucuta DC Clin Transl Oncol; 2019 Jun; 21(6):702-712. PubMed ID: 30387047 [TBL] [Abstract][Full Text] [Related]
12. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis. Sun X; Roudi R; Dai T; Chen S; Fan B; Li H; Zhou Y; Zhou M; Zhu B; Yin C; Li B; Li X BMC Cancer; 2019 Jun; 19(1):558. PubMed ID: 31182061 [TBL] [Abstract][Full Text] [Related]
13. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Mahoney KM; Freeman GJ; McDermott DF Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918 [TBL] [Abstract][Full Text] [Related]
15. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Jiang Y; Chen M; Nie H; Yuan Y Hum Vaccin Immunother; 2019; 15(5):1111-1122. PubMed ID: 30888929 [TBL] [Abstract][Full Text] [Related]
16. [Current events in immunotherapy for upper aerodigestive tract cancer]. Outh-Gauer S; Le Tourneau C; Broudin C; Scotte F; Roussel H; Hans S; Mandavit M; Tartour E; Badoual C Ann Pathol; 2017 Feb; 37(1):79-89. PubMed ID: 28111039 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers]. Duruisseaux M; Rouquette I; Adam J; Cortot A; Cazes A; Gibault L; Damotte D; Lantuejoul S Ann Pathol; 2017 Feb; 37(1):61-78. PubMed ID: 28162296 [TBL] [Abstract][Full Text] [Related]
18. PD-1 as a potential target in cancer therapy. McDermott DF; Atkins MB Cancer Med; 2013 Oct; 2(5):662-73. PubMed ID: 24403232 [TBL] [Abstract][Full Text] [Related]
19. Checkpoint inhibitors in AML: are we there yet? Ghosh A; Barba P; Perales MA Br J Haematol; 2020 Jan; 188(1):159-167. PubMed ID: 31808941 [TBL] [Abstract][Full Text] [Related]
20. The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer. van Dam LS; de Zwart VM; Meyer-Wentrup FA Pediatr Blood Cancer; 2015 Feb; 62(2):190-197. PubMed ID: 25327979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]